G1 Therapeutics Inc (NAS:GTHX)
$ 7.15 0 (0%) Market Cap: 377.22 Mil Enterprise Value: 364.45 Mil PE Ratio: 0 PB Ratio: 15.31 GF Score: 31/100

G1 Therapeutics Inc COSELA Kickoff Analyst and Investor Summit - Corporate Call Transcript

Apr 09, 2021 / 01:00PM GMT
Release Date Price: $25.57 (+1.35%)
William C. Roberts
G1 Therapeutics, Inc. - VP of IR & Corporate Communications

Good morning, everyone, I hope you and yours are healthy and well. My name is Will Roberts. I'm the Vice President and Head of Corporate Communications and Investor Relations here at G1 Therapeutics. I'm excited to welcome you today to the G1 COSELA Kickoff, our 2021 investor event. It's a pack 2-hour agenda, which I'll get to in a moment, but first, a couple of things to keep in mind.

First of all, this presentation does include forward-looking statements. And actual results could differ materially from those expressed in or implied by these forward-looking statements. So for more information on these forward-looking statements, I recommend that you go to sec.gov or to our G1 Therapeutics website and take a look at our filings with the SEC.

Secondly, as you know, we'll be talking today about our product COSELA, the only proactive multilineage myeloprotection therapy, which was approved by the U.S. Food and Drug Administration on February 12 of this year to decrease the incidence of chemotherapy-induced

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot